WTC
GMAB icon

WhitTier Trust Company’s Genmab GMAB Stock Holding History

WhitTier Trust Company’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-93
Closed -$1.82K – 1460
2025
Q1 		$1.82K Sell
93
-123
-57% -$2.58K ﹤0.01% 1294
2024
Q4 		$4.5K Buy
216
+28
+15% +$615 ﹤0.01% 1157
2024
Q3 		$4.58K Hold
188
– – ﹤0.01% 1131
2024
Q2 		$4.72K Hold
188
– – ﹤0.01% 1078
2024
Q1 		$5.62K Hold
188
– – ﹤0.01% 1023
2023
Q4 		$5.99K Buy
188
+85
+83% +$2.67K ﹤0.01% 1012
2023
Q3 		$3.63K Hold
103
– – ﹤0.01% 1028
2023
Q2 		$3.91K Hold
103
– – ﹤0.01% 1050
2023
Q1 		$3.89K Buy
+103
New +$3.96K ﹤0.01% 1036

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

WhitTier Trust Company's GMAB Position: Q2 2025 in Review

WhitTier Trust Company sold out of Genmab (GMAB) in Q2 2025, closing a stake of 93 shares — an estimated $1.82K sold.

WhitTier Trust Company first reported a position in GMAB in Q1 2023 and held it in 9 quarters. The position peaked at $5.99K in Q4 2023. 217 funds tracked by Wall St. Rank hold GMAB as of Q2 2025.

  • WhitTier Trust Company reported no remaining Genmab position as of Q2 2025 after selling out during the quarter.
  • WhitTier Trust Company sold 93 Genmab shares in Q2 2025, an estimated $1.82K.
  • WhitTier Trust Company first reported a position in Genmab in Q1 2023 and held it in 9 quarters.
  • WhitTier Trust Company's Genmab position peaked at $5.99K in Q4 2023.
  • 217 funds tracked by Wall St. Rank held Genmab as of Q2 2025.

Based on WhitTier Trust Company's 13F filing for Q2 2025, filed 30 Jul 2025.